Selecta Biosciences Inc. (RNAC) - Rasio kapitalisasi marang bathi resik

Cartesian Therapeutics (RNAC) owns a state-of-the-art facility in Maryland featuring autonomous bioreactor life-support systems. This price chart reflects the asset's dynamics, where the indicator stands at -1.60. The company is implementing innovative treatments for cancer and autoimmune pathologies, which minimizes price competition. However, high development costs and the lack of a steady cash flow create significant financial threats to the business.

RNAC selectabio.com: Koefisien rega marang bathi ing interval 21.02.2024 - 10.11.2026

Rincian metrik komprehensif lan analitis Cartesian Therapeutics Inc (RNAC)

- rega pasar lan target rega analis:

Rega bursa selectabio.com|RNAC - Prakiraan konsensus analis

- indikator kapitalisasi pasar:

Kapitalisasi pasar Cartesian Therapeutics, Inc.|RNAC - Rega Nyata Tumbas Perusahaan Kanthi Wutuh

- data nilai buku modal saham:

Nilai Aset Bersih saben Saham Cartesian Therapeutics|RNAC - Aset Bersih Perusahaan|Nilai Pasar marang Nilai Buku selectabio.com|RNAC - Total Aset Perusahaan

- statistik kawajiban utang lan likuiditas:

Rasio Total Utang marang Ekuitas Cartesian Therapeutics|RNAC - Utang jangka dawa marang modal|Kewajiban jangka cendhak marang modal Selecta Biosciences Inc.|RNAC - Utang perusahaan|Rasio utang marang kapitalisasi buku Cartesian Therapeutics, Inc.|RNAC - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Cartesian Therapeutics|Rasio jangkoan perantara selectabio.com

- data bathi bisnis lan rasio investasi:

RNAC - Bathi resik|Proyeksi bathi resik Cartesian Therapeutics|RNAC - Pangali P/E|Rasio prakiraan rega marang bathi Selecta Biosciences|RNAC - Rasio rega marang bathi tumrap wutah|Nilai perusahaan marang bathi operasional sadurunge panyusutan Cartesian Therapeutics, Inc.|RNAC - Bathi operasional EBITDA|Bathi resik saben siji saham sajrone rolas wulan pungkasan Cartesian Therapeutics|RNAC - Bathi resik saben saham sajrone 12 wulan pungkasan|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan selectabio.com|RNAC - Wutah bathi resik saben saham ing taun iki|Proyeksi tambahing bathi saben saham ing taun ngarep Cartesian Therapeutics

Analisis komprehensif perusahaan:selectabio.com

Produk mawa merek Cartesian Therapeutics, Inc.

The unique RNA platform of Cartesian Therapeutics (RNAC) creates a technological barrier against classic CAR-T, enhancing the business value. The market capitalization to net income ratio determines the value of each unit of earnings, reflecting market expectations for scalability. The price action regarding the company's target P/E demonstrates a balance between an innovation premium and the risk of overpayment. This asset belongs to the venture class with a high bet on scientific novelty.

Analisis perusahaan pesaing

Kapitalisasi marang bathi legendbiotech.com LEGN|Pangali P/E SANA|Autolus Therapeutics PLC (AUTL) - Rasio kapitalisasi marang bathi resik|Allogene Therapeutics Inc - Koefisien rega marang bathi|Cellectis SA (CLLS) - Kapitalisasi marang bathi|CRBU: Koefisien rega marang bathi|Nilai perusahaan marang bathi resik TIL (instilbio.com)|GNTA: Pangali P/E|Koefisien rega marang bathi Century Therapeutics, Inc.|JSPR (Jasper Therapeutics Inc) - Pangali P/E|Kapitalisasi marang bathi Senti Biosciences Inc SNTI|Rasio rega marang bathi Adaptimmune (ADAP)|Rasio rega marang bathi CERO (cero.bio)|Rasio rega marang bathi Alaunos Therapeutics, Inc. TCRT|Achilles Therapeutics PLC - Rasio rega marang bathi|CRGX: Koefisien rega marang bathi|Nilai perusahaan marang bathi resik PSTX (Poseida Corp)|TSVT: Pangali P/E|Rasio kapitalisasi marang bathi resik gracellbio.com GRCL